tiprankstipranks
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market
ANRO
Alto Neuroscience, Inc.
RESEARCH TOOLSreports

Alto Neuroscience, Inc. (ANRO) Stock News & Sentiment

563 Followers
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
Premium
Company Announcements
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
8d ago
8K
ANRO
Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback
Premium
Ratings
Pipeline Strength and Key Late-Stage Assets Drive Upside in Alto Neuroscience Despite ALTO-101 Setback
8d ago
ANRO
Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile
Premium
Ratings
Alto Neuroscience: Advancing Late-Stage CNS Pipeline and Strengthened Balance Sheet Support Favorable Risk-Reward Profile
23d ago
ANRO
Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating
Premium
Ratings
Alto Neuroscience: Advancing Precision-Psychiatry Pipeline and De-Risked Trials Support Buy Rating
23d ago
ANRO
Alto Neuroscience Secures $120 Million Private Placement Financing
Premium
Company Announcements
Alto Neuroscience Secures $120 Million Private Placement Financing
24d ago
8K
ANRO
Alto Neuroscience, Inc.: Promising Future with Strategic Advancements and Strong Financial Position
Premium
Ratings
Alto Neuroscience, Inc.: Promising Future with Strategic Advancements and Strong Financial Position
5M ago
ANRO
Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Innovative Treatment Prospects
Premium
Ratings
Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Innovative Treatment Prospects
5M ago
ANRO
More ANRO News >

ANRO News on the Web

Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO)
TipRanks News
Neutral
Alto Neuroscience’s ALTO-101 miss doesn’t impact thesis, says H.C. Wainwright
TipRanks News
Neutral
Alto Neuroscience price target lowered to $21 from $22 at Wedbush
TipRanks News
Bearish
Morning Movers: Immunovant sinks after batoclimab trials miss goal
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Alto Neuroscience, Inc. (ANRO)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Alto Neuroscience, Inc. (ANRO) and Viridian Therapeutics (VRDN)
TipRanks News
Bullish
Alto Neuroscience price target lowered to $38 from $41 at Baird
TipRanks News
Bearish
Alto Neuroscience price target lowered to $44 from $49 at JonesResearch
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
ANRO
Sector Average
Media Buzz
This Week1 articles
Weekly Average8 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANRO’s Media Buzz Sentiment?
1 articles about ANRO were published this week. In an average week, 8 articles are published.
    What is ANRO’s weekly average amount of articles?
    In an average week, 8 articles about ANRO are published.
      What is ANRO’s News Sentiment?
      50% of articles about ANRO were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        ORGOOrganogenesis Holdings
        HUMHumana
        STAAStaar Surgical
        Showing the stocks with the most bullish news sentiment over the past week